News Release VacciXcell



Esco VacciXcell at World Vaccine Congress in Barcelona, Spain


Oct 20, 2017


Esco VacciXcell Spain Team with Esco Healthcare President, XL Lin at Booth 1329 at Crowne Plaza Hotel

Esco VacciXcell recently participated in the World Vaccine Congress Exhibition held in Crown Plaza Hotel Barcelona, Spain from October 10-12, 2017. The congress brought together scientific scope, breadth, and partners from around the globe.

Esco VacciXcell with its absolute commitment and endeavor to help significantly in Healthcare industry, showcased the CelCradle™ benchtop bioreactor and the new and improved TideCell® for sustainable bioprocessing. CelCradle and TideCell are bioreactors that utilize the proprietary Tide Motion principle which provides a better framework for culture optimization.

One of the main advantages of VacciXcell's Tide Motion Bioreactor system is that it features the same bioprocess method from seed preparation to production scale. CelCradle is a single-use bioreactor that can be used not only for cell cultivation but also as a platform for vaccine research and development for its capability of producing high virus titer. TideCell also attracted a lot of scientists since it is designed to embody a closed, continuous process that aims to help biomanufacturing companies to improve product yield, especially for vaccine production. For visitors who looked for a multi-functional bioreactor, the Hybrid bioreactor is perfect for different types of culture whether it is suspension or adherent.

Given the magnitude of the public health challenge the world is facing, Esco VacciXcell continues to help and work with biomanufacturing companies to improve the health of thousands of people living with a disease.